The Second Chance is a patented, safe, and easy to use vacuum device for removing a lodged mass or bolus from the throat of a choking victim. The device includes a pump for creating a vacuum chamber which is connected seamlessly with a replaceable/disposable mouthpiece. In an emergency the CRD may be easily inserted into the victim’s mouth which depresses the tongue providing a clear, trauma-free application.
By pressing a button on the device, the device will deliver the appropriate amount of instantaneous vacuum to dislodge the mass or bolus in the throat without harm or damage to the victim. The application is instantly effective as the device is operational and effective in a matter of seconds.
The Company believes its anti-choking device will quickly become the “accepted” standard and leader in the treatment of choking incidents globally. The Company’s anti-choking device is designed to quickly, safely and economically address a medical situation that occurs often, is indiscriminate of time and place, is complex, time-sensitive, and if treated incorrectly can cause unintended or unexpected injury and even death.
The Second Chance ACD has a number of advantages, features and two patents. The highlights are:
Easy to Use – The product is designed to be used by adults and children. The tongue depressor vacuum tube is inserted vs. trying to place and keep a mask on a traumatized patient
Smart Patented Design – The product is designed specifically to immobilize the palate from reflex spasm and open the air passage using a replaceable tongue depressor vacuum tube. A controlled vacuum action, with specific negative pressure, has been carefully calculated enabling the lifting of a lodged mass from the throat, so it may be ejected by reflexive coughing.
Usable on anyone – The CRD can be used on infants to elderly adults. Also, it can be use on pregnant women and others who the Heimlich Maneuver cannot help.
Self-administrable– The CRD will be self-administrable by adults.
The Second Chance Opportunity
The Company believes the opportunity for success is significant given the focus on health and safety in the US and most of the modern world. There are approximately 5,000 choking deaths annually in the US. 95% of these result from in-home incidents. 56% of these victims are over 74 years in age. Choking is the 4th leading cause of death in children, and airway obstruction is the leading cause of unintentional injury-related deaths under the age of 1 in the United States. Current choking rescue devices do not address these needs.
Consider, for comparison, carbon monoxide (CO) detectors. The National Fire Protection Organization estimates that during the period 1999-2010 there were, on average, 430 unintentional CO poisoning deaths per year, a number far smaller than choking deaths. Nonetheless, 42% of US (approximately 48 million total) households have working CO detectors.
The Company expects that the infant segment of the market will be particularly important. The Second Chance CRD will be sold at a price consistent with baby shower presents such as baby monitors. Reaching just a few percent of the approximately 4,000,000 births per year in the US could potentially yield sales of hundreds of thousands of units.